Skip to content

Effect of Premature Luteinization on the Oocyte Quality in Oocyte Donation Program.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00455949
Enrollment
Unknown
Registered
2007-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2007-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Luteinization

Brief summary

Analyze the possible effect of the progesterone levels of the hCG administration on the oocyte embryo quality. The primary endpoint of this study is the pregnancy rate.

Interventions

None listed

Sponsors

Instituto Valenciano de Infertilidad, IVI VALENCIA
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 34 Years
Healthy volunteers
Yes

Inclusion criteria

* Oocyte donors; age range: 18 - 34; BMI: 18 - 29; long protocol.

Exclusion criteria

* PCO syndrome;

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026